SCHEMBL17884625

SCHEMBL17884625

NCCCOCCOCCOCCCNC(=O)C(F)(F)F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ POLB P06746 1/20 0.61
▸ MEN1 O00255 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ CA3 P07451 2/20 0.53
▸ CA5A P35218 2/20 0.53
▸ CA5B Q9Y2D0 2/20 0.53
▸ CA14 Q9ULX7 2/20 0.53
▸ CA12 O43570 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA4 P22748 1/20 0.53
▸ CA6 P23280 1/20 0.53
▸ CA7 P43166 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ EPHX1 P07099 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.42
▸ GLA P06280 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25766759 1.00 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL25031841 0.93 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL3149189 0.86 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL12116757 0.85 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL14253741 0.85 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL6490885 0.84 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
Hydrochloric Acid SCHEMBL29241548 0.84 SMN1; SMN2 (0.71) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL12833035 0.83 SMN1; SMN2 (0.52) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
Hydrochloric Acid SCHEMBL29241679 0.82 SMN1; SMN2 (0.75) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL5367616 0.82 MEN1 (0.79) ALDH1A1SMN1; SMN2POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017007612-A1 METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-01-12 — — WO disclosed
WO-2016105518-A1 METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-06-30 — — WO disclosed
Send feedback